Join
Live feed
·
PRReleasevia Quantisnow
Aeterna Zentaris Inc. logo

Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

ByQuantisnow·Wall Street's wire, on your screen.
AEZS· Aeterna Zentaris Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AEZS (Aeterna Zentaris Inc.) and more on Quantisnow.